Divergent effects of levetiracetam and tiagabine against spontaneous seizures in adult rats following neonatal hypoxia.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Epilepsy Research

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.eplepsyres.2017.12.006PMID 29227795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies.

  2016cited by this paper
• Optogenetic activation of superior colliculus neurons suppresses seizures originating in diverse brain networks.

  2016cited by this paper
• Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression

  2015cited by this paper
• odels of hypoxia and ischemia-induced seizures

  2015cited by this paper
• Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.

  2015cited by this paper
• Delayed Effect of Craniotomy on Experimental Seizures in Rats

  2013cited by this paper
• Antiepileptic effects of levetiracetam in a rodent neonatal seizure model

  2013cited by this paper
• AMPA Receptor antagonist NBQX attenuates later‐life epileptic seizures and autistic‐like social deficits following neonatal seizures

  2013cited by this paper
• Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome

  2013cited by this paper
• Mammalian target of rapamycin complex 1 activation negatively regulates Polo-like kinase 2-mediated homeostatic compensation following neonatal seizures

  2013cited by this paper
• The Synaptic Vesicle Glycoprotein 2A Ligand Levetiracetam Inhibits Presynaptic Ca2+ Channels through an Intracellular Pathway

  2012cited by this paper
• Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.

  2011cited by this paper
• Development of later life spontaneous seizures in a rodent model of hypoxia‐induced neonatal seizures

  2011cited by this paper
• Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy.

  2010cited by this paper
• Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.

  2010cited by this paper
• Epileptogenesis in the immature brain: emerging mechanisms

  2009cited by this paper
• Tiagabine: efficacy and safety in partial seizures – current status

  2008cited by this paper
• Typical versus Atypical Absence Seizures: Network Mechanisms of the Spread of Paroxysms

  2007cited by this paper
• Effects of levetiracetam on spike and wave discharges in WAG/Rij rats.

  2004cited by this paper
• Levetiracetam protects against kainic acid-induced toxicity.

  2004cited by this paper
• The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

  2004cited by this paper
• Effeclis of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats

  2003cited by this paper
• Status Epilepticus and Tiagabine Therapy: Review of Safety Data and Epidemiologic Comparisons

  2001cited by this paper
• Tiagabine in Clinical Practice

  2001cited by this paper
• Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?

  2001cited by this paper
• Early identification of refractory epilepsy.

  2000cited by this paper
• Mossy fiber sprouting after recurrent seizures during early development in rats

  1999cited by this paper
• Two Cases of Nonconvulsive Status Epilepticus in Association with Tiagabine Therapy

  1999cited by this paper
• Review of Controlled Trials of Gabitril (Tiagabine): A Clinician's Viewpoint

  1999cited by this paper
• Activity-dependent enhancement of hyperpolarizing and depolarizing gamma-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine.

  1999cited by this paper
• Tiagabine-induced absence status in idiopathic generalized epilepsy.

  1999cited by this paper
• Mossy fiber sprouting after recurrent seizures during early development in rats.

  1999cited by this paper
• Inhibitory nature of tiagabine-augmented GABAA receptor-mediated depolarizing responses in hippocampal pyramidal cells.

  1999cited by this paper
• Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.

  1998cited by this paper
• Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin.

  1997cited by this paper
• Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat.

  1997cited by this paper
• Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.

  1996cited by this paper
• NBQX Blocks Acute and Late Epileptogenic Effects of Perinatal Hypoxia

  1995cited by this paper
• Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.

  1995cited by this paper
• A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor

  1995cited by this paper
• Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.

  1993cited by this paper
• ucb L059, a novel anti-convulsant drug: pharmacological profile in animals.

  1992cited by this paper
• Synaptic reorganization by mossy fibers in human epileptic fascia dentata.

  1991cited by this paper
• Epileptogenic effect of hypoxia in the immature rodent brain

  1991cited by this paper
• Clinico-biochemical and molecular studies of purine nucleoside phosphorylase deficiency.

  1988cited by this paper
• Neonatal Hypoxia and Epileptic Risk: A Clinical Prospective Study

  1984cited by this paper

• Unveiling the Critical Moments: How Early‐Life Seizures Shape Adult Epileptogenesis

  2025cites this paper
• Anti-seizure medication-induced developmental cell death in neonatal rats is unaltered by history of hypoxia.

  2024cites this paper
• Temporal development of seizure threshold and spontaneous seizures after neonatal asphyxia and the effect of prophylactic treatment with midazolam in rats.

  2024influential citation
• Phenobarbital does not worsen outcomes of neonatal hypoxia on hippocampal LTP on rats

  2023influential citation
• Sex-Dependent Signaling Pathways Underlying Seizure Susceptibility and the Role of Chloride Cotransporters

  2019cites this paper
• Age-Dependency of Levetiracetam Effects on Exocytotic GABA Release from Nerve Terminals in the Hippocampus and Cortex in Norm and After Perinatal Hypoxia

  2019cites this paper
• The Ischemic Immature Brain: Views on Current Experimental Models

  2018cites this paper
• Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.

  2018cites this paper